Filed: 11/14/2025ACC: 0000919574-25-006891
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $22.86M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$22.86M
Total AUM (reported)
2.19M
Total Shares
Allocation by class
COM NEW$19.04M83.3%
GOLD SHS$2.59M11.3%
COM$898.9K3.9%
CL B NEW$327.5K1.4%
Portfolio Concentration
Top 3$21.59M94.5%
4–10$1.23M5.4%
11–25$39.8K0.2%
Top 3 weight
94.5%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 2.19M
Sole
Full voting authority
2.19M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
REZOLUTE INC
SOLEShares1.99M
TypeSH
Market value$18.68M
81.70%
Sole
1.99M
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares7.29K
TypeSH
Market value$2.59M
11.33%
Sole
7.29K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares651.00
TypeSH
Market value$327.5K
1.43%
Sole
651.00
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares27.01K
TypeSH
Market value$318.5K
1.39%
Sole
27.01K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares13.10K
TypeSH
Market value$268.1K
1.17%
Sole
13.10K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares53.50K
TypeSH
Market value$187.3K
0.82%
Sole
53.50K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$172.8K
0.76%
Sole
10.94K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$137.9K
0.60%
Sole
22.98K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.33K
TypeSH
Market value$115.1K
0.50%
Sole
17.33K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares16.39K
TypeSH
Market value$26.6K
0.12%
Sole
16.39K
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$22.0K
0.10%
Sole
10.94K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$17.8K
0.08%
Sole
18.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REZOLUTE INCSOLE | COM NEW | 1.99M | SH | $18.68M 81.70% | 1.99M | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 7.29K | SH | $2.59M 11.33% | 7.29K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 651.00 | SH | $327.5K 1.43% | 651.00 | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 27.01K | SH | $318.5K 1.39% | 27.01K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 13.10K | SH | $268.1K 1.17% | 13.10K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 53.50K | SH | $187.3K 0.82% | 53.50K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 10.94K | SH | $172.8K 0.76% | 10.94K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $137.9K 0.60% | 22.98K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.33K | SH | $115.1K 0.50% | 17.33K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 16.39K | SH | $26.6K 0.12% | 16.39K | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 10.94K | SH | $22.0K 0.10% | 10.94K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $17.8K 0.08% | 18.40K | 0.00 | 0.00 |